Spark Therapeutics
Latest round
- Series B
Last raised
- May 2014
Total raised
- $73M
Investors
- 7
About Spark Therapeutics
Established in 2013 and based in Pennsylvania, US, Spark Therapeutics, Inc. operates as a developer of a gene therapy platform that helps in discovering treatments for genetic diseases. The company uses adeno-associated viral (AAV) vectors for investigational research.
Who invested in Spark Therapeutics
7 investors across 1 round
See all investors in Spark Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 27, 2014
Amount
$73M
Investors
Questions about Spark Therapeutics
Who invested in Spark Therapeutics?
Spark Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spark Therapeutics raised?
Spark Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Spark Therapeutics last raise money?
Spark Therapeutics's most recent round on record is a Series B, in May 2014.
What does Spark Therapeutics do?
Established in 2013 and based in Pennsylvania, US, Spark Therapeutics, Inc.
Where is Spark Therapeutics headquartered?
Spark Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Spark Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Spark Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Spark Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.